ArticleJournal of biomedical science2026

Dual suppression of stemness and redox adaptation in glioblastoma through filaggrin upregulation by an abiraterone-based HDAC inhibitor.

Hoang Yen Tran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.